Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
Medical & Biological Engineering & Computing|August 13, 2015
Heart rate analysis by sparse representation for acute pain detectionShai Tejman-Yarden, Ofer Levi, Alex Beizerov, et al.Sexually Transmitted Infections|October 21, 2020
Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UKCharlotte O'Halloran, Sara Croxford, Hamish Mohammed, et al.Plos One|November 1, 2024
Changes in urgent and emergency care activity associated with COVID-19 lockdowns in a sub-region in the East of England: Interrupted times series analysesZillur Rahman Shabuz, Max Bachmann, Rachel Cullum, et al.Scientific Reports|January 25, 2013
Selection of nanobodies that target human neonatal Fc receptorJan Terje Andersen, Maria Gonzalez-Pajuelo, Stian Foss, et al.Sexually Transmitted Infections|April 24, 2019
Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in EnglandHolly D Mitchell, Sarika Desai, Hamish Mohammed, et al.Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.Inflammatory Bowel Diseases|April 18, 2012
Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelinesTimothy L Zisman, Mary P Bronner, Stephen Rulyak, et al.Journal of Biomolecular Screening|October 4, 2011
Epigenetic drug discovery: targeting DNA methyltransferasesJason M Foulks, K Mark Parnell, Rebecca N Nix, et al.Science (New York, N.Y.)|October 27, 2018
Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cellsStéphanie Liénart, Romain Merceron, Christophe Vanderaa, et al.Mabs|February 5, 2014
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockadeKaren Silence, Torsten Dreier, Mahan Moshir, et al.Pageof 12